Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

NCT05998135 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Ovarian High Grade Serous Adenocarcinoma
Platinum-Resistant Ovarian Carcinoma

Interventions

DRUG: Atovaquone
PROCEDURE: Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Paracentesis

Sponsor

Emory University

Collaborators

[object Object]